Robeco Institutional Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.3M Buy
171,500
+74,934
+78% +$27.8M 0.08% 231
2026
Q1
$28.3M Buy
96,566
+65,668
+213% +$21.6M 0.04% 309
2025
Q4
$10.8M Sell
30,898
-27,362
-47% -$9.25M 0.02% 423
2025
Q3
$18.8M Sell
58,260
-31,653
-35% -$9.84M 0.03% 361
2025
Q2
$35M Sell
89,913
-28,402
-24% -$11.4M 0.06% 271
2025
Q1
$51.5M Sell
118,315
-12,810
-10% -$5.14M 0.1% 187
2024
Q4
$48.4M Sell
131,125
-76,916
-37% -$32.2M 0.09% 200
2024
Q3
$108M Sell
208,041
-26,790
-11% -$14.3M 0.21% 104
2024
Q2
$127M Sell
234,831
-5,197
-2% -$2.75M 0.27% 78
2024
Q1
$124M Sell
240,028
-17,802
-7% -$8.85M 0.27% 85
2023
Q4
$122M Buy
257,830
+23,487
+10% +$10.9M 0.29% 81
2023
Q3
$102M Sell
234,343
-24,159
-9% -$11M 0.27% 89
2023
Q2
$115M Sell
258,502
-36,365
-12% -$16.8M 0.3% 81
2023
Q1
$136M Sell
294,867
-207,536
-41% -$98.8M 0.37% 73
2022
Q4
$258M Sell
502,403
-204,672
-29% -$104M 0.74% 25
2022
Q3
$321M Sell
707,075
-21,300
-3% -$10.2M 1.04% 12
2022
Q2
$352M Buy
728,375
+24,698
+4% +$12.2M 1.09% 13
2022
Q1
$346M Buy
703,677
+35,653
+5% +$16.3M 0.81% 20
2021
Q4
$310M Buy
668,024
+70,681
+12% +$29.7M 0.66% 33
2021
Q3
$223M Buy
597,343
+5,559
+0.9% +$2.11M 0.49% 44
2021
Q2
$226M Buy
591,784
+137,574
+30% +$52.6M 0.5% 43
2021
Q1
$163M Buy
454,210
+4,511
+1% +$1.45M 0.4% 66
2020
Q4
$144M Sell
449,699
-45,517
-9% -$14M 0.38% 67
2020
Q3
$133M Buy
495,216
+12,387
+3% +$3.33M 0.41% 61
2020
Q2
$127M Sell
482,829
-4,281
-0.9% -$1.14M 0.43% 52
2020
Q1
$111M Buy
487,110
+12,015
+3% +$3.27M 0.44% 45
2019
Q4
$143M Sell
475,095
-60,869
-11% -$16.8M 0.46% 44
2019
Q3
$129M Sell
535,964
-19,997
-4% -$5.48M 0.45% 48
2019
Q2
$157M Buy
555,961
+2,521
+0.5% +$689K 0.55% 35
2019
Q1
$159M Buy
553,440
+25,122
+5% +$7.27M 0.58% 28
2018
Q4
$139M Sell
528,318
-136,551
-21% -$37.5M 0.62% 27
2018
Q3
$182M Sell
664,869
-49,682
-7% -$12.9M 0.72% 20
2018
Q2
$170M Sell
714,551
-13,109
-2% -$3.04M 0.77% 20
2018
Q1
$160M Buy
727,660
+17,646
+2% +$4.15M 0.75% 20
2017
Q4
$160M Buy
710,014
+224,126
+46% +$47.7M 0.83% 19
2017
Q3
$92.3M Buy
485,888
+44,454
+10% +$8.46M 0.57% 44
2017
Q2
$83M Buy
441,434
+194,670
+79% +$35M 0.53% 50
2017
Q1
$40.8M Buy
246,764
+218,143
+762% +$34.7M 0.27% 110
2016
Q4
$4.12M Sell
28,621
-231,777
-89% -$31M 0.03% 403
2016
Q3
$32.6M Sell
260,398
-28,140
-10% -$3.63M 0.24% 125
2016
Q2
$37.9M Sell
288,538
-5,337
-2% -$730K 0.29% 114
2016
Q1
$40.8M Sell
293,875
-26,984
-8% -$3.61M 0.33% 102
2015
Q4
$44.7M Sell
320,859
-206,731
-39% -$28.5M 0.38% 77
2015
Q3
$73.9M Sell
527,590
-6,619
-1% -$995K 0.56% 38
2015
Q2
$87.7M Buy
534,209
+128,866
+32% +$20.6M 0.67% 33
2015
Q1
$62.6M Buy
405,343
+148,738
+58% +$21.2M 0.47% 53
2014
Q4
$32.2M Buy
256,605
+135,575
+112% +$16.8M 0.23% 121
2014
Q3
$14.5M Buy
121,030
+52,367
+76% +$6.01M 0.1% 216
2014
Q2
$7.39M Buy
68,663
+864
+1% +$89K 0.05% 275
2014
Q1
$6.75M Buy
67,799
+16,772
+33% +$1.52M 0.05% 270
2013
Q4
$4.71M Buy
51,027
+4,088
+9% +$363K 0.04% 289
2013
Q3
$3.92M Sell
46,939
-1,978
-4% -$170K 0.04% 300
2013
Q2
$4M Buy
+48,917
New +$3.66M 0.04% 296

Other funds holding ELV

Robeco Institutional Asset Management's ELV Position: Q2 2026 in Review

Robeco Institutional Asset Management increased its Elevance Health (ELV) stake by 78% in Q2 2026, buying an estimated $27.8M and bringing the position to 171,500 shares worth $66.3M. The position accounts for 0.08% of the portfolio, ranked #231.

Robeco Institutional Asset Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $352M in Q2 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Robeco Institutional Asset Management held 171,500 shares of Elevance Health worth $66.3M as of Q2 2026.
  • Robeco Institutional Asset Management bought 74,934 Elevance Health shares in Q2 2026, an estimated $27.8M.
  • Elevance Health made up 0.08% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #231 holding.
  • Robeco Institutional Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Robeco Institutional Asset Management's Elevance Health position peaked at $352M in Q2 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.